Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
about
Immune thrombocytopeniaPathophysiology and management of primary immune thrombocytopenia.Increased percentages of T cells producing interleukin-21 in patients with immune thrombocytopenic purpura.Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines.Platelet antibody analysis by three different tests.Changes in follicular helper T cells in idiopathic thrombocytopenic purpura patients.Antibody binding to megakaryocytes in vivo in patients with immune thrombocytopenia.Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitorA distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia.Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-AntibodiesEmerging drugs for immune thrombocytopenia (ITP).The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia.Molecular mimicry in Helicobacter pylori infections.Clinical Significance of T-Cell Immunoglobulin Mucin 3 Expression on Peripheral Blood Mononuclear Cells in Pediatric Acute Immune Thrombocytopenia.Purtscher's retinopathy as the presenting manifestation of immune thrombocytopenic purpura.FC gamma receptor polymorphisms in patients with immune thrombocytopenia.Common Variable Immunodeficiency Non-Infectious Disease Endotypes Redefined Using Unbiased Network Clustering in Large Electronic Datasets.Emerging Concepts in Immune Thrombocytopenia.
P2860
Q26830918-21B049A6-D494-4757-99B4-49799D700E7BQ33407942-32F06618-2D4F-4086-9F68-C39CFCB70780Q33412014-8C963F2D-BF83-4F9B-8B04-9391FF57C239Q33414858-89C7AC18-AC0F-4343-9422-F3B526D9A556Q33415071-D65F99B8-7E68-40AC-8212-2782853D7542Q33419621-BA867B9D-F68E-4DD8-BC8A-8C7E389D1C42Q33420459-663E0193-DD8C-4EED-804E-27F6C53AF330Q33425412-3A44AE83-CB20-468D-A591-7C8117C3AD26Q33430662-7D69ECB3-F1FF-424F-80D0-589BE3731675Q33434374-A19A8EFB-F5B0-4ED1-95D1-FF02F723068FQ33439789-0C713E20-921A-4DD8-A470-0FC737D493EEQ33441391-79713A49-D3B0-41F9-ACDA-CD77311674CEQ33805866-C8AF5942-5605-4FEC-A3C9-E4FFAF36A89EQ46429214-57F9DCFF-3E0C-4319-882A-58B597164A53Q47128992-4631DFB8-B628-4466-AA16-F5E34F8E570EQ48299475-8C1B8D20-0A57-4E27-AD4E-E56223A6CE3AQ49469643-72971E71-4A1E-452F-A6F6-33D873211285Q54211951-A912AF3D-9BA7-41D2-B7C7-5AD751D9FF84
P2860
Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Autoantibody-mediated compleme ...... hrombocytopenic purpura (ITP).
@ast
Autoantibody-mediated compleme ...... hrombocytopenic purpura (ITP).
@en
type
label
Autoantibody-mediated compleme ...... hrombocytopenic purpura (ITP).
@ast
Autoantibody-mediated compleme ...... hrombocytopenic purpura (ITP).
@en
prefLabel
Autoantibody-mediated compleme ...... hrombocytopenic purpura (ITP).
@ast
Autoantibody-mediated compleme ...... hrombocytopenic purpura (ITP).
@en
P2093
P2860
P1476
Autoantibody-mediated compleme ...... hrombocytopenic purpura (ITP).
@en
P2093
Abderrahim Najaoui
Gregor Bein
Johanna Stoy
Mathias J Rummel
Tamam Bakchoul
Ulrich J Sachs
P2860
P304
P356
10.1111/J.1600-0609.2011.01718.X
P577
2011-11-22T00:00:00Z